Shuren: At-home technologies must be fit-for-purpose
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsCombination products/companion diagnosticsComplianceDiagnostics/IVDsMedical DevicesNorth AmericaOtherPharmaceuticalsProduct LifecycleRegulatory Intelligence/PolicyResearch, Design and Development